Tonix Pharmaceuticals Holding Corp (TNXP)
0.196
-0.01
(-4.02%)
USD |
NASDAQ |
Nov 22, 14:09
Tonix Pharmaceuticals Total Assets (Quarterly): 94.99M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 94.99M |
June 30, 2024 | 70.31M |
March 31, 2024 | 135.34M |
December 31, 2023 | 154.46M |
September 30, 2023 | 139.28M |
June 30, 2023 | 159.74M |
March 31, 2023 | 179.09M |
December 31, 2022 | 225.69M |
September 30, 2022 | 242.65M |
June 30, 2022 | 276.16M |
March 31, 2022 | 223.72M |
December 31, 2021 | 240.90M |
September 30, 2021 | 214.77M |
June 30, 2021 | 189.16M |
March 31, 2021 | 183.52M |
December 31, 2020 | 98.18M |
September 30, 2020 | 67.62M |
June 30, 2020 | 58.34M |
March 31, 2020 | 33.93M |
December 31, 2019 | 14.56M |
September 30, 2019 | 12.27M |
June 30, 2019 | 15.01M |
March 31, 2019 | 20.02M |
December 31, 2018 | 26.32M |
September 30, 2018 | 16.06M |
Date | Value |
---|---|
June 30, 2018 | 18.36M |
March 31, 2018 | 20.98M |
December 31, 2017 | 26.75M |
September 30, 2017 | 30.54M |
June 30, 2017 | 35.82M |
March 31, 2017 | 23.78M |
December 31, 2016 | 27.51M |
September 30, 2016 | 29.80M |
June 30, 2016 | 34.32M |
March 31, 2016 | 31.35M |
December 31, 2015 | 47.02M |
September 30, 2015 | 57.82M |
June 30, 2015 | 50.93M |
March 31, 2015 | 60.47M |
December 31, 2014 | 39.54M |
September 30, 2014 | 47.33M |
June 30, 2014 | 45.06M |
March 31, 2014 | 50.20M |
December 31, 2013 | 8.736M |
September 30, 2013 | 7.570M |
June 30, 2013 | 0.3144M |
March 31, 2013 | 0.5945M |
December 31, 2012 | 2.117M |
September 30, 2012 | 0.19M |
June 30, 2012 | 1.526M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.56M
Minimum
Dec 2019
276.16M
Maximum
Jun 2022
150.12M
Average
157.10M
Median
Total Assets (Quarterly) Benchmarks
Emergent BioSolutions Inc | 1.478B |
Geovax Labs Inc | 11.11M |
Abbott Laboratories | 74.36B |
Amicus Therapeutics Inc | 786.56M |
United Therapeutics Corp | 7.123B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 20.78M |
Shareholders Equity (Quarterly) | 74.21M |
Debt to Equity Ratio | 0.1077 |
Current Ratio | 3.329 |
Net Debt Paydown Yield | -1.21% |